The Fox Chase Chemical Diversity Center, Inc. (FCCDC)

 

The Fox Chase Chemical Diversity Center Announces That It Is Working Together With the Wistar Institute in Philadelphia

 

Doylestown, PA. February 7, 2012- FCCDC is pleased to announce that it is working together with the Wistar Institute in Philadelphia to discover new small molecule inhibitors to treat Epstein Barr virus and associated cancers, as part of a multi-year Wellcome Trust Seeding Drug Discoveryaward. FCCDC will perform the medicinal chemistry portion of the project and aid in other aspects of the early drug discovery research effort.